Pornpimol Charoentong
Overview
Explore the profile of Pornpimol Charoentong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
8666
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Pflugler S, Svinka J, Scharf I, Crncec I, Filipits M, Charoentong P, et al.
Commun Biol
. 2020 May;
3(1):252.
PMID: 32444775
Tumors have evolved mechanisms to escape anti-tumor immunosurveillance. They limit humoral and cellular immune activities in the stroma and render tumors resistant to immunotherapy. Sensitizing tumor cells to immune attack...
12.
Schopf B, Weissensteiner H, Schafer G, Fazzini F, Charoentong P, Naschberger A, et al.
Nat Commun
. 2020 Mar;
11(1):1487.
PMID: 32198407
Rewiring of energy metabolism and adaptation of mitochondria are considered to impact on prostate cancer development and progression. Here, we report on mitochondrial respiration, DNA mutations and gene expression in...
13.
Finotello F, Mayer C, Plattner C, Laschober G, Rieder D, Hackl H, et al.
Genome Med
. 2019 Jul;
11(1):50.
PMID: 31358023
It was highlighted that the original article [1] contained a typesetting mistake in the name of Noel Filipe da Cunha Carvalho de Miranda. This was incorrectly captured as Noel Filipe...
14.
Finotello F, Mayer C, Plattner C, Laschober G, Rieder D, Hackl H, et al.
Genome Med
. 2019 May;
11(1):34.
PMID: 31126321
We introduce quanTIseq, a method to quantify the fractions of ten immune cell types from bulk RNA-sequencing data. quanTIseq was extensively validated in blood and tumor samples using simulated, flow...
15.
Kather J, Krisam J, Charoentong P, Luedde T, Herpel E, Weis C, et al.
PLoS Med
. 2019 Jan;
16(1):e1002730.
PMID: 30677016
Background: For virtually every patient with colorectal cancer (CRC), hematoxylin-eosin (HE)-stained tissue slides are available. These images contain quantitative information, which is not routinely used to objectively extract prognostic biomarkers....
16.
van Montfoort N, Borst L, Korrer M, Sluijter M, Marijt K, Santegoets S, et al.
Cell
. 2018 Dec;
175(7):1744-1755.e15.
PMID: 30503208
Tumor-infiltrating CD8 T cells were found to frequently express the inhibitory receptor NKG2A, particularly in immune-reactive environments and after therapeutic cancer vaccination. High-dimensional cluster analysis demonstrated that NKG2A marks a...
17.
The Anatomical Location Shapes the Immune Infiltrate in Tumors of Same Etiology and Affects Survival
Santegoets S, van Ham V, Ehsan I, Charoentong P, Duurland C, van Unen V, et al.
Clin Cancer Res
. 2018 Sep;
25(1):240-252.
PMID: 30224343
Purpose: The tumor immune microenvironment determines clinical outcome. Whether the original tissue in which a primary tumor develops influences this microenvironment is not well understood. Experimental Design: We applied high-dimensional...
18.
Kather J, Suarez-Carmona M, Charoentong P, Weis C, Hirsch D, Bankhead P, et al.
Elife
. 2018 Sep;
7.
PMID: 30179157
Lymphoid and myeloid cells are abundant in the tumor microenvironment, can be quantified by immunohistochemistry and shape the disease course of human solid tumors. Yet, there is no comprehensive understanding...
19.
Kather J, Charoentong P, Suarez-Carmona M, Herpel E, Klupp F, Ulrich A, et al.
Cancer Res
. 2018 Jul;
78(17):5155-5163.
PMID: 29967263
Solid tumors are rich ecosystems of numerous different cell types whose interactions lead to immune escape and resistance to immunotherapy in virtually all patients with metastatic cancer. Here, we have...
20.
Efremova M, Rieder D, Klepsch V, Charoentong P, Finotello F, Hackl H, et al.
Nat Commun
. 2018 Jan;
9(1):32.
PMID: 29296022
The cancer immunoediting hypothesis postulates a dual role of the immune system: protecting the host by eliminating tumor cells, and shaping the tumor by editing its genome. Here, we elucidate...